Key scientific achievements expand the pipeline of high value molecular glue degraders for unmet medical needsPerformance-based and program-based payments of in total US$ 75 m to Evotec HAMBURG, DE / ...

GOTHENBURG, SE / ACCESS Newswire / April 24, 2025 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV)First quarter 2025 (Jan-Mar)Net sales increased to SEK 218.6 million (186.0), corresponding to ...

ATLANTA, GEORGIA / ACCESS Newswire / April 23, 2025 / Black Book Research today announced the release of its comprehensive ...

Swiss MedTech leader taps renowned pediatric innovation expert to serve as Chief Strategy and Innovation Officer and Head of ...

Collaborations are important in biopharma manufacturing because biologic medicines, particularly new modalities, such as ...

A new report reveals disparities in chimeric antigen receptor (CAR) T-cell therapy delivery across Europe, with healthcare ...

SAN DIEGO, CA / ACCESS Newswire / April 23, 2025 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) (the "Company"), a clinical-stage pharmaceutical company developing innovative solutions for severe pain ...

DELRAY BEACH, FL / ACCESS Newswire / April 23, 2025 / Adolore BioTherapeutics ("Adolore" or the "Company") is developing intracellularly-delivered neuromodulators that naturally reduce neuronal ...

Groundbreaking longevity research initiative brings together leading scientists and institutions to decode the genetic basis of extreme lifespan BROOKLYN, NEW YORK / ACCESS Newswire / April 23, 2025 / ...

Applies TAAP and MPAR Technology to Produce Novel OUD Treatments ~~ Prioritizes Safety and Tolerability for OUD Patients ~ SAN DIEGO, CA / ACCESS Newswire / April 23, 2025 / Ensysce Biosciences, Inc.

Microsoft Azure customers worldwide now gain access to Ambience's AI platform for health systems, to take advantage of the scalability, reliability, and agility to drive application development and ...

NEWARK, CA / ACCESS Newswire / April 23, 2025 / Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") announced that an abstract was accepted for presentation at the Plenary Session at the ...